Table 1.
Pairwise comparison | No. upregulated DEGs | No. downregulated DEGs |
---|---|---|
Challenge 14 DPV | ||
3 DPC vs. 0 DPV | 58 | 7 |
6 DPC vs. 0 DPV | 40 | 4 |
9 DPC vs. 0 DPV | 71 | 2 |
14 DPC vs. 0 DPV | 81 | 15 |
21 DPC vs. 0 DPV | 47 | 4 |
42 DPC vs. 0 DPV | 94 | 55 |
Challenge 7 DPV | ||
3 DPC vs. 0 DPV | 45 | 19 |
6 DPC vs. 0 DPV | 10 | 23 |
9 DPC vs. 0 DPV | 101 | 604 |
14 DPC vs. 0 DPV | 18 | 12 |
21 DPC vs. 0 DPV | 13 | 23 |
42 DPC vs. 0 DPV | 21 | 80 |
Challenge 3 DPV | ||
3 DPC vs. 0 DPV | 42 | 2 |
6 DPC vs. 0 DPV | 197 | 588 |
9 DPC vs. 0 DPV | 47 | 41 |
14 DPC vs. 0 DPV | 25 | 5 |
21 DPC vs. 0 DPV | 35 | 15 |
42 DPC vs. 0 DPV | 127 | 118 |
DEGs are defined as those with at least 2-fold change in expression relative
to 0 DPV with an FDR-corrected p value <0.05 and an average RPKM of 5.
The DEGs listed are protein-coding and human homolog genes.
DEG, differentially expressed genes; DPV, days post-vaccination; No., number; DPC, days post-challenge.